FDA Clearance Tracker · P210027-S012
QDOT MICRO System
Last checked: Nov 20, 2026Latest source record: Apr 8, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Apr 8, 2025
Approved
Time to decision
258 days
Received Jul 24, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P210027-S012
- Device name
- QDOT MICRO System
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- Jul 24, 2024
- Decided
- Apr 8, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P210027
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
PAS protocol changes to retrospectively consent patients enrolled in REAL-AF Sites and to include the Zero/Low Fluoro Workflow.
Source documents
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.